Latest news with #GEHealthcare
Yahoo
5 days ago
- Business
- Yahoo
InfuSystems Holdings Inc (INFU) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and ...
Release Date: August 05, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Revenue grew by 7% to $36 million, with gross margins expanding by 574 basis points to 55.2%. Adjusted EBITDA increased by 32% year-over-year to $8 million, with the EBITDA margin improving by 427 basis points to 22.3%. Net income increased by 262%, and cash flows from operations more than doubled. The company returned approximately $3.5 million to shareholders through stock repurchases during the quarter. The relationship with Smith and Nephew is progressing well, showing promise for sustained growth with minimal upfront capital requirements. Negative Points The revenue growth outlook for 2025 has been updated to a range of 6 to 8%, down from the previous range of 8 to 10%. There is a delay in the rollout of additional increases in advanced wound care volumes due to necessary processing improvements. The company has removed 2025 revenue forecasts for the chemo mouthpiece product due to changes in reimbursement coding. The biomedical services relationship with GE Healthcare is under restructuring due to unmet margin expectations. The ERP implementation is expected to impact adjusted EBITDA margin by nearly 200 basis points in 2025, with completion anticipated in early 2026. Q & A Highlights Warning! GuruFocus has detected 4 Warning Signs with INFU. Q: With oncology showing strong cash flow, is mid-single-digit growth a reasonable expectation for this business going forward? A: (CEO) Yes, mid-single-digit growth makes sense for us. We have been seeing some subtle increases in volumes, which are certainly hopeful, but I think mid-single-digit growth is a reasonable expectation. Q: Can you provide more details on the GE Healthcare contract and its impact on the top line? A: (CFO) The GE Healthcare contract is about a $7 to $8 million business annually. We are working with GE to make changes that will help us create value for them while also improving our margins. Q: Regarding the acquisition of Apollo, will it drive efficiencies beyond the wound care business? A: (CEO) Yes, while we will start with wound care, we plan to extend the efficiencies to our broader platform, including oncology, once stabilized. Q: How is the ERP system implementation progressing, and what can we expect in terms of future expenses? A: (CFO) The ERP project is progressing well, currently in the blueprint stage. We expect to go live in the first quarter of 2026, with costs around half a million dollars per quarter until then. Post-implementation, we anticipate productivity improvements. Q: With expanding margins, what levers are you planning to utilize, and how should we think about that going forward? A: (CFO) Improved margins are due to growth and internal efficiencies. We expect to sustain low 20s margins, excluding ERP expenses, as we continue to grow. Q: Can you provide an update on the timeline for resolving reimbursement challenges for the chemo mouthpiece? A: (CEO) We expect to hear back by the end of the year regarding coding, with reimbursement rates established by July next year. Q: How should we think about the mix shift towards lower-margin wound care and its impact on long-term margins? A: (CFO) While wound care has decent gross margins, we are working on improving claim processing to enhance profitability. Once resolved, it should positively impact cash flow margins. Q: Is the 42% margin in device solutions sustainable, and what drives its outperformance compared to patient services? A: (CFO) The margin is driven by rental growth and efficient cost management. While it may fluctuate, we expect it to hold its own, with potential variations based on sales mix. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. 登入存取你的投資組合
Forbes
24-07-2025
- Health
- Forbes
The Role Of Quality Engineering In Safeguarding Medical Decisions
Gopinath Kathiresan is a veteran QE leader combining AI, cybersecurity and automation to build smarter, secure software. AI is transforming healthcare, from interpreting scans to powering early warning systems that guide diagnosis and treatment. In fact, according to a 2024 McKinsey survey, around 70% of healthcare organizations are now using or planning to use generative AI. But AI is not without risk. Earlier in my career, I worked at GE Healthcare and Bio-Rad Laboratories, where I saw how small software issues could carry clinical consequences. One misfire in device communication or a delayed result in a diagnostic tool could mean a missed treatment window. That's why, in healthcare, quality doesn't just mean good code. It means protecting patients in real-world, high-stakes moments. Why Healthcare AI Needs A New Kind Of Oversight AI in healthcare is advancing fast. Models now help detect tumors, predict readmissions, flag deteriorating patients and assist with triage decisions. A 2023 study in Lancet Digital Health even found that AI-based diagnostic tools, such as those for skin cancer detection, can sometimes match or outperform specialists, especially novice specialists. But performance in a controlled environment doesn't always translate to the chaos of real-world hospitals. We can't assume an algorithm is 'good enough' just because it clears a data scientist's benchmark. We need to engineer for safety from the start. That means moving beyond static accuracy numbers and thinking deeply about how AI performs under pressure, across patient types and in unpredictable situations. The Limitations Of Traditional QA In Medical AI Earlier in my career as a quality engineer, I worked on regulated diagnostic software and medical device platforms. I contributed to test automation for verification workflows, validated device communication and ensured clinical accuracy standards were met. That hands-on experience shaped how I think about risk, reliability and patient safety in software and the importance of quality engineering (QE) in healthcare. Healthcare organizations have long practiced software testing. But testing AI is a different beast. AI models behave probabilistically. They're trained on datasets that might not reflect the populations they serve. Their outputs evolve as conditions shift. A tool that performs with 95% accuracy in one hospital might drop dramatically in another, due to differences in demographics, calibrations or data quality. In fact, research has shown that rural hospitals or hospitals with fewer resources, for example, may buy AI tools off-the-shelf, meaning the data the AI is trained on looks different than their hospital's population, which can impact performance. This is where QE must step in, not just as a checkpoint, but as a design partner focused on: • Bias detection across patient populations. • Edge-case testing for rare or high-risk conditions. • Explainability validation to ensure clinicians can interpret results. • Monitoring for model drift after deployment. Quality engineers aren't just testing systems; they're safeguarding patients. From Bugs To Bias: What A Modern QE Pipeline Looks Like The FDA has acknowledged this new frontier, and its updates to its software as a medical device (SaMD) guidelines show that the agency is acknowledging both AI's potential and risk. While its guidance isn't finalized, they are focusing on several aspects of how AI can impact medical devices, including ongoing monitoring and performance validation for AI and machine learning tools. But real-world safety demands more than checkboxes. It requires QE practices that validate AI performance not only at launch but also throughout its lifecycle. So what does 'clinical-grade' QE look like in practice? Emerging best practices include: • Scenario-Based Test Automation: QE teams should consider how these tools will work in real-world scenarios. For example, researchers at the SIMNOVA Simulation Center developed an AI workflow to create and test realistic healthcare simulation scenarios. • Synthetic Data Injection: Synthetic data can help to round out data samples during testing. For example, Stanford's RoentGen project improved classifier accuracy using synthetic chest X-rays. • Demographic Audit Layers: Mainly because of the data it's trained on, AI can perform differently based on factors like a patient's ethnicity or gender, emphasizing the importance of fairness audits • Collaborative Validation: Subject matter experts, such as clinicians and other healthcare stakeholders, should be included in the AI design process to ensure that issues that impact the real-world use of these tools are considered. This shift isn't just a technical evolution; it's foundational to trust in healthcare AI. AI Won't Replace Testers—It'll Make Their Role Even More Critical There's a common fear that AI might make testers obsolete. In healthcare, the opposite is true. AI may help automate test generation and monitor systems post-deployment, but human quality engineers bring what AI can't: context, curiosity and caution. Humans should ask: • 'Would this still work in an emergency room?' • 'Is the model unintentionally learning the wrong patterns?' • 'Could this mislead a busy nurse under pressure?' That kind of judgment is forged from hands-on experience. No AI system, no matter how advanced, can replace the human instinct to ask, 'What could go wrong here?' If you're in healthcare tech, this is a call to action: • Testers: Learn AI model behavior and where quality gaps emerge. • Developers: Collaborate with QE teams early during integration. • Leaders: Treat quality as foundational, not a bolt-on. What matters most isn't what AI can do in theory, but how it behaves when seconds count, when a nurse or physician is making a call that could save a life. The Role Quality Must Play In Saving Lives Software doesn't just support healthcare anymore; it is healthcare. And as AI becomes more central to decisions, QE must evolve from assurance to active defense. I've spent over 15 years working in software quality, including time in regulated healthcare. I've seen how fragile trust becomes when tools fail, and how powerful it is when teams get it right. Now more than ever, we need QE professionals to be the silent guardians of patient safety, testing not just for bugs, but for bias, breakdowns and blind spots. Because when AI enters the hospital, the question isn't just 'Does it work?' It's about whether it will protect the patient when it truly counts. Forbes Technology Council is an invitation-only community for world-class CIOs, CTOs and technology executives. Do I qualify?
Egypt Today
19-06-2025
- Business
- Egypt Today
PM tours factories manufacturing ultrasound machines, televisions and mobile screens
PM Madbouly during his inspection tour at 6 of October factories CAIRO - 19 JUNE 2025: Egyptian Prime Minister Dr. Mostafa Madbouly began Thursday his inspection tour of several factories in 6 of October City that manufacture ultrasound machines, televisions, and mobile phones. As part of his tour, Dr. Mostafa Madbouly, Prime Minister, inspected the project to establish the first factory in Africa and the Middle East to manufacture ultrasound machines and magnetic resonance imaging (MRI) devices, located in 6th of October City. This project is considered an important step towards strengthening Egypt's position as a regional center for medical technology. This project is the result of a strategic partnership between GE Healthcare, a global leader in medical technology and digital solutions, and Medinova, a subsidiary of Al Safi Group. The goal is to develop an advanced facility in Egypt for the production of medical imaging devices, contributing to improving the quality of diagnostic healthcare and supporting the goals of Egypt's Vision 2030. Upon his arrival at the factory site, the Prime Minister affirmed that the Egyptian state is taking serious steps toward localizing several important industries and deepening the industry, with the participation of the local and foreign private sector, which has become a strategic partner in various development projects implemented by the state. There is also a strong trend toward localizing vital industries and strengthening international partnerships. In this context, Dr. Mostafa Madbouly explained that he had met with the CEO of GE Healthcare at the end of last year to review the project to manufacture ultrasound devices in Egypt. "As a government, we are confident that this will be a pioneering project in this field and will achieve the Egyptian state's goals in its plan to localize medical industries and devices," Madbouly said, emphasizing that the ongoing cooperation with GE Healthcare embodies an ambitious national vision aimed at advancing the healthcare system in Egypt. For his part, the Deputy Prime Minister for Human Development and Minister of Health and Population praised the ongoing cooperation with the company, noting that localizing the medical device industry is a priority for the Ministry of Health. He expressed his appreciation for the company's choice of Egypt to localize the manufacture of ultrasound devices, in order to meet the needs of the Egyptian market and subsequently expand and export, particularly to Africa. In this context, Dr. Khaled Abdel Ghaffar explained that the project to establish the first factory in Egypt and the Middle East to manufacture ultrasound devices "is a milestone in the history of manufacturing." The National Medical Center will directly contribute to supporting the healthcare sector's infrastructure, improving the quality of diagnostic services, and reducing reliance on imports. This will support market stability and provide advanced healthcare solutions for Egyptian citizens. During the tour, Dr. Khaled Abdel Ghaffar, Deputy Prime Minister and Minister of Health and Population, reviewed the project's advantages, which go beyond manufacturing, but also include the transfer and localization of technology and the training of Egyptian cadres. This will enhance human resource efficiency and strengthen local capabilities to transform Egypt into a regional center for the manufacture of advanced medical devices. He emphasized the Ministry of Health's continued support for these efforts, in coordination with various ministries and institutions, to achieve health, economic, and social development goals. Dr. Khaled Abdel Ghaffar added that this initiative comes within the framework of an integrated strategy adopted by the Ministry of Health and Population, in cooperation with the Egyptian Authority for Unified Procurement, Medical Supply and Supply, and the Medical Technology Department, and with the participation of relevant state authorities. This aims to support the local pharmaceutical and medical equipment industries, in line with the goals of Egypt Vision 2030, which aims to diversify the economy, develop strategic industries, and provide new job opportunities for Egyptian youth, while enhancing the country's export capacity to regional markets, particularly African markets. At the same time, The Deputy Prime Minister indicated that the establishment of the factory is a "strategic step toward establishing the foundations for a medical future whose components are manufactured by Egyptian hands. It opens broad horizons for a national healthcare system that is competitive, resilient in the face of challenges, and efficient in meeting the needs of Egyptian citizens." For his part, Mark Stoesz, President Enterprise Solutions and Partnerships International Markets at GE Healthcare, emphasized that "there are several motivations that encouraged us as a manufacturing company to establish operations in Egypt, most notably the Egyptian government's growing interest in healthcare, a focus that has not wavered or diminished despite the economic challenges facing the Egyptian government." He added that Egypt's large market, home to approximately 110 million citizens, also contributes to making Egypt a hub for entry into the African market. During his tour of the project, the Prime Minister listened to an explanation from Eng. Mohamed Haroun, General Manager of GE Healthcare Africa, who indicated that the new facility will localize the manufacturing and assembly of ultrasound and MRI systems to meet the growing demand in both the public and private sectors. By localizing these vital industries, the initiative contributes to achieving several pillars of Egypt's Vision 2030, including enhancing economic diversification, creating new job opportunities, and achieving self-sufficiency in medical technology. He added: "The factory will also enable the export of devices to regional markets, particularly in Africa, strengthening Egypt's role as a regional hub for innovation and production in the healthcare sector." Dr. Mostafa Madbouly also visited the site of a project to manufacture television and phone screens at the Safi Group factory in 6 of October city. He viewed the board production line, how they are manufactured, and how they are tested before moving on to the next production stage to ensure their safety. He then moved on to learn about the router production line, and then went to see the TV screen assembly stage. Meanwhile, the Prime Minister inquired about the percentage of local components, with the factory manager indicating that a large percentage of local components are relied upon in manufacturing, and there is a trend towards increasing this percentage in the coming stages. Engineer Safi Wahba, Founder and Chairman of Al Safi Investment Group, indicated that the total area of the Al Safi factory (which includes production lines for ultrasound and magnetic resonance imaging devices, in addition to production lines for communications devices, mobile phones, television screens, and others) is 25,000 square meters. The direct workforce is 2,000, while the indirect workforce is 1,000, with 25 production lines. The production capacity of the ultrasound factory is approximately 2,500 devices annually, while the production capacity of the MRI factory ranges between 40 and 50 devices annually. During his tour of the project, the Prime Minister learned about the various stages of the manufacturing plan, which include raw material inspection, device assembly points, software development, and manufacturing technology. Meanwhile, Dr. Khaled Abdel Ghaffar noted that the devices to be manufactured in this project are the same types of devices used in hospitals, whose equipment is being modernized and upgraded. Similar devices will also be used in the presidential "Decent Life" initiative to develop rural Egyptian villages, which will significantly reduce the import bill. Before concluding his inspection tour of the project, the Prime Minister reiterated his government's willingness to provide the company with all necessary support and facilities, encouraging it to explore manufacturing more medical devices beyond ultrasound machines. The Prime Minister was accompanied during his inspection tour of the project site by Dr. Khaled Abdel Ghaffar, Deputy Prime Minister for Human Development and Minister of Health and Population; Lieutenant General Kamel El Wazir, Deputy Prime Minister for Industrial Development and Minister of Industry and Transport; Eng. Adel El Naggar, Governor of Giza; Dr. Ali El Ghamrawy, Head of the Egyptian Drug Authority; and Dr. Hisham Steit, Head of the Egyptian Authority for Unified Procurement, Medical Supply, and Medical Technology Management. The event was welcomed by Mark Stoesz, President Enterprise Solutions and Partnerships International Markets at GE Healthcare; Eng. Safi Wahba, Founder and Chairman of Al Safi Group Investment; Dr. Hazem El Far, Chairman of Medinova, a subsidiary of Al Safi Group; Eng. Mohamed Haroun, General Manager of GE Healthcare Africa; Eng. Diaa Shaarawy, Chief Operating Officer of Al Safi Group; Eng. Islam Adel, General Manager of the Plant; and Maxime Auger, General Manager of the Ultrasound Division.
Yahoo
16-06-2025
- Business
- Yahoo
Medtech earnings estimates may see 'significant' upward revisions
Tariffs have been weighing on medical device makers' earnings outlook all year. David Roman, Goldman Sachs head of US medtech and healthcare IT research, joins Market Domination to explain why many in the medtech industry are now set up for upward revisions of earnings estimates. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. as you had the chance to talk to folks in the MedTech industry here, it seems like one of the biggest headwinds this year has been concerned over tariffs, right? And the fact that at least some of this stuff gets made in China and other areas abroad and imported here to the US. So I'd love to start there and get your take on what you're hearing from these companies. Excellent. Uh, thank you for having me today. Uh, so you're right. Tariffs has been a major concern for investors. That did drive companies to lower their outlooks for 2025 on most recent earnings calls. If you listen to the first quarter earnings calls, most companies did take take reductions reflecting the then in place tariffs. If you look at MedTech though in context, about 70% of medical devices sold in the US are actually made in the US. This is a significant amount of onshore manufacturing. And unlike some other parts of healthcare where you do see the move of IP around the world for for to to manage effective tax rates, MedTech R&D is very heavily domiciled in the US. So as we as we reflect on kind of where tariff policy sits today, we actually expect fairly significant upward revisions and earnings estimates as we go through second quarter earnings, uh, to take into account what are obviously tariff rates that are moderated, especially on China from what we saw during the April, uh, April earnings season. That's those supply chain stats are interesting, David. How has it always been like that or has there been a shift in the last 5 or 10 years in that industry? So it's actually been a pretty long-standing strategy for MedTech companies to manufacture where they sell. And and and I think it's it's a good point because that trend did accelerate during, uh, the first round, the first Trump administration when tariffs went into place. But remember, the medical device industry is very much a manufacturing industry. So things like freight and logistics costs do go into the calculation when companies think about where to put manufacturing. It also allows them to compete locally. So for example, most take GE Healthcare, who has about 12% of their revenue in China, something like 70 to 80% of what they manu of what they sell in China is manufactured, uh, and sourced locally. And that puts them in a position to be able to compete effectively with companies who are domestically headquartered there. The same is true in the US. Uh, companies try to put manufacturing very close to where they do R&D, and the reason for that is rapid prototyping and, um, trying to accelerate the development of products because this is very much a iterative industry. Putting product development and manufacturing closely aligned to one another has actually been a competitive advantage for several companies.
Yahoo
05-06-2025
- Business
- Yahoo
[Latest] Global Internet of Medical Things IoMT Market Size/Share Worth USD 1061.49 Billion by 2034 at a 16.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT)
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Internet of Medical Things IoMT Market size & share revenue was valued at approximately USD 242.80 Billion in 2024 and is expected to reach USD 276.85 Billion in 2025 and is expected to reach around USD 1061.49 Billion by 2034, at a CAGR of 16.1% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Boston Scientific Corporation, General Electric Company (GE Healthcare), Johnson & Johnson Services Inc., Medtronic, Koninklijke Philips N.V., Siemens Healthineers AG, Cisco, IBM, Baxter (Hill-Rom Services Inc.), BIOTRONIK, and others. Austin, TX, USA, June 05, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled 'Internet of Medical Things (IoMT) Market Size, Trends, and Insights By Offering Type (General Purpose Reloadable Card, Gift Cards, Incentive/Payroll Card, Others), By Card Type (Closed Loop Prepaid Card, Open Loop Prepaid Card), By End User Industry (Retail, Healthcare, Travel and Hospitality, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034' in its research database. 'According to the latest research study, the demand of the global Internet of Medical Things IoMT Market size & share was valued at approximately USD 242.80 Billion in 2024 and is expected to reach USD 276.85 Billion in 2025 and is expected to reach a value of around USD 1061.49 Billion by 2034, at a compound annual growth rate (CAGR) of about 16.1% during the forecast period 2025 to 2034.' Click Here to Access a Free Sample Report of the Global Internet of Medical Things (IoMT) Market @ Internet of Medical Things IoMT Market Overview As per the industry experts at CMI, The global Internet of Medical Things (IoMT) market is growing rapidly due to increasing demand for connected healthcare and real-time monitoring. Leading players like Medtronic, GE Healthcare, Philips, Boston Scientific, and Johnson & Johnson are advancing smart devices and AI-powered diagnostics. These businesses position themselves on interoperable and secure platforms for optimized data exchange to participate effectively in healthcare value chains. Governments and healthcare systems unite with IoMT to provide chronic disease management for aging populations. Digital technology companies, in partnership with IoMT, to accelerate innovation and entry into the market. Relationships with technology (such as 5G, artificial intelligence, and edge technology) enable these products to improve and respond. As the market develops, these companies begin to target expansion outside of the national borders and employ a total digital healthcare ecosystem. Internet of Medical Things IoMT Market Growth Factors and Dynamics Increased Demand for Remote Patient Monitoring: Remote Patient Monitoring (RPM) uses connected medical devices to send health data to providers in real-time, thus allowing continuous care outside of clinical settings, thus benefitting chronic disease management and helping to support elderly care. Additionally, as Artificial Intelligence (AI) matures, the development of AI-enhanced RPM systems continues to be greatly anticipated. There are already AI-driven aspects of RPM, including the recognition of health deterioration early, personalized monitoring using federated learning, and behavior pattern identification through reinforcement learning. As these aspects matured, it offered an increased RPM capacity for health intervention, thereby improving patient outcomes. Thus, with the evolution of healthcare, RPM systems are quickly moving toward becoming in-demand and essential future healthcare technologies. It has been noted that RPM systems also reduce hospital readmissions, thus offering a cost-effective solution. Advancements in Wireless Technology: Advancements in wireless technology, such as 5G networks and low-power communication protocols have dramatically improved the functionality of Internet of Medical Things (IoMT) devices. These advancements offer faster data transmission, lower latency, and improved connectivity that make real-time monitoring and data analysis in the healthcare setting much more competent. Additionally, advancements in micro-computing and compact hardware allow for even greater innovation in the IoMT, enabling system innovations that now support timely diagnostics and remote monitoring of chronic conditions. But these advancements have also expanded the attack surface for security risks. Addressing these issues is necessary in order to protect patients and data integrity. Overall, the advancements in wireless technology are changing the way healthcare is delivered. Request a Customized Copy of the Internet of Medical Things (IoMT) Market Report @ Integration with AI and Big Data: The integration of Artificial Intelligence (AI) and Big Data analytics into Internet of Medical Things systems (IoMT) has disrupted the healthcare sector by enabling the processing of massive health datasets. Thus, it allows for predictive analytics, early detection of diseases, and highly individualized treatment plans. Likewise, AI-driven RPM systems are now able to detect early signs of patient decline, personalize monitoring through federated learning, and determine a patient's behaviors based on reinforcement learning. All of this enables years of proactive healthcare management, contributing to significant improvements in patient health. Furthermore, the system still provides a support role for healthcare providers and ultimately contributes to making healthcare better and more efficient. Report Scope Feature of the Report Details Market Size in 2025 USD 276.85 Billion Projected Market Size in 2034 USD 1061.49 Billion Market Size in 2024 USD 242.80 Billion CAGR Growth Rate 16.1% CAGR Base Year 2024 Forecast Period 2025-2034 Key Segment By Offering Type, Card Type, End User Industry and Region Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends Regional Scope North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America Buying Options Request tailored purchasing options to fulfil your requirements for research. (A free sample of the Internet of Medical Things IoMT report is available upon request; please contact us for more information.) Our Free Sample Report Consists of the following: Introduction, Overview, and in-depth industry analysis are all included in the 2024 updated report. The COVID-19 Pandemic Outbreak Impact Analysis is included in the package. About 220+ Pages Research Report (Including Recent Research) Provide detailed chapter-by-chapter guidance on the Request. Updated Regional Analysis with a Graphical Representation of Size, Share, and Trends for the Year 2025 Includes Tables and figures have been updated. The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis Custom Market Insights (CMI) research methodology (Please note that the sample of the Internet of Medical Things IoMT report has been modified to include the COVID-19 impact study prior to delivery.) Request a Customized Copy of the Internet of Medical Things IoMT Market Report @ Internet of Medical Things IoMT Market SWOT Analysis Strengths: The IoMT (Internet of Medical Things) market is based on the increased speed of connectivity, artificial intelligence, and sensor capabilities. The IoMT improves monitoring of patients, diagnosing, and treating; the evidence suggests improved health outcomes. Collecting and presenting data in real time helps improve clinical decisions and productivity. Adoption in existing healthcare systems (particularly in developed regions) continues to support the growth of the market. Innovation is also driven by the increased demand for remote care and wearables. Support from large healthcare providers, along with socio economic factors that support economic development, enables momentum for the IoMT. Weaknesses: The complex integration of many devices and many platforms persists as a principal issue related to IoMT. Substantial issues remain for patients and providers in terms of data security and privacy as well as cybersecurity risks. The upfront capital costs, complexity of adoption, and healthcare systems in many regions of the world (many with a lack of capital in developing regions) undermine the development of IoMT systems further. In specific instances, there may be regulatory barriers to market with IoMT devices and long periods without approval. In rural areas, internet connectivity issues may seriously inhibit the rollout of systems. The level of continuing education and digital literacy amongst staff in healthcare systems (e.g. nurses) can also inhibit the use of IoMT devices. Opportunities: The continued rollout of telemedicine services (e.g., telehealth) constitutes a significant opportunity for IoMT integration. The need for IoMT solutions is exacerbated by our aging population and chronic diseases, while there is the potential for investment in healthcare systems, particularly in emerging economies. The integration of artificial intelligence offers a market opportunity to drive predictive analytics and personalized healthcare. Partnerships are forming between technology firms, IoMT companies, and healthcare providers, which could lead to exciting innovations in the future; additionally, new government programs focused on digital health can help accelerate this process. Threats: A cybersecurity breach could result in catastrophic breaches of sensitive health data and loss of trust in any health system. A regulated market creates dependencies and appears to be an adversarial process, especially when compliance changes occur and regulatory delays arise. Continued lack of awareness of the myriad of devices joining the IoMT market is an insidious threat that can continue to undermine its potential. Competitive pressures are tremendous, increasing price risks and limiting profit margins. Other worsening economic drivers could reduce, limit, or void budgets and capital for healthcare IT. Traditional healthcare systems tend to be slow and resistant to changes, which increasingly protracts and limits adoption. Request a Customized Copy of the Internet of Medical Things IoMT Market Report @ Key questions answered in this report: What is the size of the Internet of Medical Things (IoMT) market, and what is its expected growth rate? What are the primary driving factors that push the Internet of Medical Things (IoMT) market forward? What are the Internet of Medical Things (IoMT) Industry's top companies? What are the different categories that the Internet of Medical Things (IoMT) Market caters to? What will be the fastest-growing segment or region? In the value chain, what role do essential players play? What is the procedure for getting a free copy of the Internet of Medical Things (IoMT) market sample report and company profiles? Key Offerings: Market Share, Size & Forecast by Revenue | 2025−2034 Market Dynamics – Growth Drivers, Restraints, Investment Opportunities, and Leading Trends Market Segmentation – A detailed analysis by Types of Services, by End-User Services, and by regions Competitive Landscape – Top Key Vendors and Other Prominent Vendors Buy this Premium Internet of Medical Things (IoMT) Research Report | Fast Delivery Available - [220+ Pages] @ Internet of Medical Things IoMT Market Regional Perspective The Internet of Medical Things IoMT Market can be divided across different regions such as North America, Europe, Asia-Pacific, and LAMEA. This is a cursory overview of each region: North America: The emphasis in the United States in 2024 has been to minimize cybersecurity risks associated with healthcare IoT devices, and the United States Energy and Commerce Committee raised the need to mitigate risks to patients and providers from cyberattacks on health facilities, which could disrupt the continuum of care. The United States Department of Veterans Affairs has included funding in their FY 2025 budget for IT modernization and expansion of digital health technologies to improve the delivery of care for veterans. In Canada, investments from 2023 through the nation's health plan have resulted in further expansion of digital health services and favored the use of IoMT throughout the country. Europe: The United Kingdom has capitalized on stakeholder resources to implement IoMT solutions to advance the digital transformation of its National Health Service, increasing patient care while also enhancing the effectiveness of the health system. Germany's landmark legislation, the Digital Healthcare Act, which was passed in 2020, supports the referral of digital health applications and IoMT devices. Germany now enables reimbursement for the use of digital health applications and extends their use into clinical practice too. In Spain, telemedicine services are expanding via IoMT engagement, improving remote patient monitoring. Spain's digital healthcare strategy is targeting the improvement of access and quality care in rural and underserved regions within the care context of increasing healthcare access. Asia-Pacific: In 2024, India created new projects for the use of Artificial Intelligence (AI) to work with IoMT device data to improve diagnosis and patient monitoring and increase access to healthcare and reduce inefficiencies. China continues to make huge investments in order to create smart healthcare infrastructures that include IoMT technologies as part of China's rejuvenation modernization strategy to improve patient outcomes. At the same time, Japan is piloting the use of robots with IoMT devices to enhance healthcare delivery by employing them to assist with patient care and improve hospital efficiency. LAMEA: Brazil is developing digital health policies aimed at increasing awareness of IoMT device adoption to improve healthcare delivery and accessibility across the country. Countries in the Middle East and Africa are also integrating healthcare technologies, including IoMT, to improve medical services. Fueled by government policies and growing private investments, these regions are working towards modernizing their healthcare capabilities and disparities while increasing patient care through technologies. Request a Customized Copy of the Internet of Medical Things IoMT Market Report @ (We customized your report to meet your specific research requirements. Inquire with our sales team about customizing your report.) Still, Looking for More Information? Do OR Want Data for Inclusion in magazines, case studies, research papers, or Media? Email Directly Here with Detail Information: support@ Browse the full 'Internet of Medical Things IoMT Market Size, Trends and Insights By Offering Type (General Purpose Reloadable Card, Gift Cards, Incentive/Payroll Card, Others), By Card Type (Closed Loop Prepaid Card, Open Loop Prepaid Card), By End User Industry (Retail, Healthcare, Travel and Hospitality, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034' Report at List of the prominent players in the Internet of Medical Things IoMT Market: Boston Scientific Corporation General Electric Company (GE Healthcare) Johnson & Johnson Services Inc. Medtronic Koninklijke Philips N.V. Siemens Healthineers AG Cisco IBM Baxter (Hill-Rom Services Inc.) BIOTRONIK Others Click Here to Access a Free Sample Report of the Global Internet of Medical Things IoMT Market @ Spectacular Deals Comprehensive coverage Maximum number of market tables and figures The subscription-based option is offered. Best price guarantee Free 35% or 60 hours of customization. Free post-sale service assistance. 25% discount on your next purchase. Service guarantees are available. Personalized market brief by author. Browse More Related Reports: Data Center Rack Market: Data Center Rack Market Size, Trends and Insights By Rack Type (Open Frame Rack, Cabinet, Others), By Rack Height (Below 42 U, 42 U, Above 42 U), By Data Center Size (Large Data Centers, Small Data Centers, Mid-sized Data Centers), By End Users (BFSI, Government & Defence, Healthcare, IT & Telecom, Energy, Retail, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033 Data Center Fire Detection and Suppression Market: Data Center Fire Detection and Suppression Market Size, Trends and Insights By Systems (Fire Detection, Fire Suppression), By Deployment Location (In Data Cabinet, Technical Space/ Room Level, Building Level), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033 Equipment As a Service Market: Equipment As a Service Market Size, Trends and Insights By Equipment (Air Compressor, Pump, Power Tools, Ground Power Units, Laser Cutting Machines, Printing Machines, CNC machines, Material handling system, Packaging Machine, Excavators, Cranes, Others), By Service Model (Pay-per-Use, Subscription-Based, Leasing, Managed Services), By End Use (Construction, Material Handling, Mining, Manufacturing, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033 Consumer Identity and Access Management Market: Consumer Identity and Access Management Market Size, Trends and Insights By component (Solution, Services), By Solution Type (Identity Governance, Identity Analytics, Identity Administration and Authentication, Identity Proofing Services), By Services (Professional Services, Managed Services), By Deployment (On-premises, Cloud), By Authentication Method (Single Sign-On (SSO), Password less Authentication, Others), By End User Industry (BFSI, Hospitality & Travel, Healthcare, Retail & E-Commerce, Education, Government & Public Sector, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033 US Anime Market: US Anime Market Size, Trends and Insights By Type (T.V., Movie, Internet Distribution, Merchandising, Music, Pachinko, Live Entertainment, Others), By Genre (Action & Adventure, Sci-Fi & Fantasy, Romance & Drama, Sports, Others), and By Region - Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033 North America Virtual Influencer Market: North America Virtual Influencer Market Size, Trends and Insights By Type (Non-human, Human Avatar), By Offering (Solution, Services), By End-Use (Food & Entertainment, Sports & Fitness, Banking & Finance, Travel & Holiday, Fashion & Lifestyle, Others), and By Region - Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033 Artificial Intelligence in Banking Market: Artificial Intelligence in Banking Market Size, Trends and Insights By Component (Service, Solution), By Application (Fraud Detection and Prevention, Transaction Monitoring, Identity Verification, Customer Service, Virtual Assistants, Automated Customer Support, Risk Management, Credit Scoring, Market Risk Analysis, Personalized Banking, Customer Recommendations, Targeted Marketing, Compliance and Regulatory Reporting, Anti-Money Laundering (AML), Know Your Customer (KYC), Others), By Technology (Machine Learning, Supervised Learning, Unsupervised Learning, Reinforcement Learning, Natural Language Processing (NLP), Text Analysis, Speech Recognition, Chatbots and Virtual Assistants, Robotic Process Automation (RPA), Process Automation, Workflow Automation, Predictive Analytics, Risk Management, Customer Insights), By Enterprise Size (Large Enterprise, SMEs), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033 Custom Software Development Services Market: Custom Software Development Services Market Size, Trends and Insights By Deployment Mode (Cloud-based, On-Premises), By Solution Type (Web/desktop-based solutions, Mobile–Based Solutions, SME's, Large Enterprises), By End User (SME's, Large Enterprises), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033 The Internet of Medical Things IoMT Market is segmented as follows: By Product Stationary Medical Devices Implanted Medical Devices Wearable External Medical Devices By Application Telemedicine Medication Management Patient Monitoring By End-user Healthcare Providers Patients Government Authorities Click Here to Get a Free Sample Report of the Global Internet of Medical Things IoMT Market @ Regional Coverage: North America U.S. Canada Mexico Rest of North America Europe Germany France U.K. Russia Italy Spain Netherlands Rest of Europe Asia Pacific China Japan India New Zealand Australia South Korea Taiwan Rest of Asia Pacific The Middle East & Africa Saudi Arabia UAE Egypt Kuwait South Africa Rest of the Middle East & Africa Latin America Brazil Argentina Rest of Latin America This Internet of Medical Things IoMT Market Research/Analysis Report Contains Answers to the following Questions. What Developments Are Going On in That Technology? Which Trends Are Causing These Developments? Who Are the Global Key Players in This Internet of Medical Things IoMT Market? What are Their Company Profile, Product Information, and Contact Information? What Was the Global Market Status of the Internet of Medical Things IoMT Market? What Was the Capacity, Production Value, Cost and PROFIT of the Internet of Medical Things IoMT Market? What Is the Current Market Status of the Internet of Medical Things IoMT Industry? What's Market Competition in This Industry, Both Company and Country Wise? What's Market Analysis of Internet of Medical Things IoMT Market by Considering Applications and Types? What Are Projections of the Global Internet of Medical Things IoMT Industry Considering Capacity, Production and Production Value? What Will Be the Estimation of Cost and Profit? What Will Be Market Share, Supply and Consumption? What about imports and exports? What Is Internet of Medical Things IoMT Market Chain Analysis by Upstream Raw Materials and Downstream Industry? What Is the Economic Impact On Internet of Medical Things IoMT Industry? What are Global Macroeconomic Environment Analysis Results? What Are Global Macroeconomic Environment Development Trends? What Are Market Dynamics of Internet of Medical Things IoMT Market? What Are Challenges and Opportunities? What Should Be Entry Strategies, Countermeasures to Economic Impact, and Marketing Channels for Internet of Medical Things IoMT Industry? Click Here to Access a Free Sample Report of the Global Internet of Medical Things IoMT Market @ Reasons to Purchase Internet of Medical Things IoMT Market Report Internet of Medical Things IoMT Market Report provides qualitative and quantitative analysis of the market based on segmentation involving economic and non-economic factors. Internet of Medical Things IoMT Market report outlines market value (USD) data for each segment and sub-segment. This report indicates the region and segment expected to witness the fastest growth and dominate the market. Internet of Medical Things IoMT Market Analysis by geography highlights the consumption of the product/service in the region and indicates the factors affecting the market within each region. The competitive landscape incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled. Extensive company profiles comprising company overview, company insights, product benchmarking, and SWOT analysis for the major market players. The Industry's current and future market outlook concerning recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging and developed regions. Internet of Medical Things IoMT Market Includes in-depth market analysis from various perspectives through Porter's five forces analysis and provides insight into the market through Value Chain. Reasons for the Research Report The study provides a thorough overview of the global Internet of Medical Things IoMT market. Compare your performance to that of the market as a whole. Aim to maintain competitiveness while innovations from established key players fuel market growth. Buy this Premium Internet of Medical Things IoMT Research Report | Fast Delivery Available - [220+ Pages] @ What does the report include? Drivers, restrictions, and opportunities are among the qualitative elements covered in the worldwide Internet of Medical Things IoMT market analysis. The competitive environment of current and potential participants in the Internet of Medical Things IoMT market is covered in the report, as well as those companies' strategic product development ambitions. According to the component, application, and industry vertical, this study analyzes the market qualitatively and quantitatively. Additionally, the report offers comparable data for the important regions. For each segment mentioned above, actual market sizes and forecasts have been given. Who should buy this report? Participants and stakeholders worldwide Internet of Medical Things IoMT market should find this report useful. The research will be useful to all market participants in the Internet of Medical Things IoMT industry. Managers in the Internet of Medical Things IoMT sector are interested in publishing up-to-date and projected data about the worldwide Internet of Medical Things IoMT market. Governmental agencies, regulatory bodies, decision-makers, and organizations want to invest in Internet of Medical Things IoMT products' market trends. Market insights are sought for by analysts, researchers, educators, strategy managers, and government organizations to develop plans. Request a Customized Copy of the Internet of Medical Things IoMT Market Report @ About Custom Market Insights: Custom Market Insights is a market research and advisory company delivering business insights and market research reports to large, small, and medium-scale enterprises. We assist clients with strategies and business policies and regularly work towards achieving sustainable growth in their respective domains. CMI provides a one-stop solution for data collection to investment advice. The expert analysis of our company digs out essential factors that help to understand the significance and impact of market dynamics. The professional experts apply client insights on aspects such as strategies for future estimation falls, forecasting or opportunities to grow, and consumer surveys. Follow Us: LinkedIn | Twitter | Facebook | YouTube Contact Us: Joel John CMI Consulting LLC 1333, 701 Tillery Street Unit 12, Austin, TX, Travis, US, 78702 USA: +1 737-734-2707 India: +91 20 46022736 Email: support@ Web: Blog: Blog: Blog: Blog: Buy this Premium Internet of Medical Things IoMT Research Report | Fast Delivery Available - [220+ Pages] @
